Pentwater Capital

Ticker	# of Shares	Price	Value
SGEN	9,629,500	$228.74	$2,202,651,830
ATVI	21,262,500	$94.42	$2,007,605,250
ATVI	21,116,300	$94.42	$1,993,801,046
HZNP	12,726,900	$116.30	$1,480,138,470
SPY	1,932,100	$746.74	$1,442,776,354
SGEN	5,634,900	$228.74	$1,288,927,026
	5,975,000	$195.32	$1,167,037,000
HZNP	9,900,000	$116.30	$1,151,370,000
	4,308,700	$195.32	$841,575,284
View Additional Portfolio Information »

A Chicago-based hedge fund launched in 2007 by manager Matthew Halbower. The fund specializes in merger arbitrage and event-driven investing.

Sep 23, 2016 05:00PM Form 4 Tobira Therapeutics, For: Sep 23 Filed by: Pentwater Capital Management LP
Sep 22, 2016 05:02PM Tobira (TBRA) Large Shareholder Pentwater Buys, Not Sells Following Allergan Deal
Sep 22, 2016 04:50PM Form SC 13G Tobira Therapeutics, Filed by: Pentwater Capital Management LP
Sep 22, 2016 04:46PM Form 4 Tobira Therapeutics, For: Sep 20 Filed by: Pentwater Capital Management LP
Sep 22, 2016 04:42PM Form 3 Tobira Therapeutics, For: Sep 20 Filed by: Pentwater Capital Management LP

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)